Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Nathan

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
The Journal of Experimental Medicine|August 1, 1993
Suppression of arthritis by an inhibitor of nitric oxide synthaseN McCartney-Francis, J B Allen, D E Mizel, et al.
The American Journal of Pathology|August 1, 1987
Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patientsG Kaplan, A Nusrat, E N Sarno, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1985
Administration of recombinant interferon gamma to cancer patients enhances monocyte secretion of hydrogen peroxideC F Nathan, C R Horowitz, J de la Harpe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Phase I trial of recombinant interferon gamma in cancer patientsS Vadhan-Raj, A Al-Katib, R Bhalla, et al.
The Journal of Surgical Research|October 27, 1999
Echocardiographic and survival studies in mice undergoing endotoxic shock: effects of genetic ablation of inducible nitric oxide synthase and pharmacologic antagonism of platelet-activating factorS C Nicholson, R T Hahn, S R Grobmyer, et al.
Shock (Augusta, Ga.)|April 29, 1999
Lethality of endotoxin in mice genetically deficient in the respiratory burst oxidase, inducible nitric oxide synthase, or bothS C Nicholson, S R Grobmyer, M U Shiloh, et al.
The Journal of Experimental Medicine|April 4, 1998
Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shockC Hierholzer, B Harbrecht, J M Menezes, et al.
Blood|January 1, 1994
Hemorrhagic tumor necrosis during a pilot trial of tumor necrosis factor-alpha and anti-GD3 ganglioside monoclonal antibody in patients with metastatic melanomaL M Minasian, T P Szatrowski, M Rosenblum, et al.
Molecular Medicine (Cambridge, Mass.)|November 7, 1999
Peptidomimetic fluoromethylketone rescues mice from lethal endotoxic shockS R Grobmyer, R C Armstrong, S C Nicholson, et al.
The Journal of Experimental Medicine|August 1, 1984
Activation of human macrophages. Comparison of other cytokines with interferon-gammaC F Nathan, T J Prendergast, M E Wiebe, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
The Journal of Experimental Medicine|August 1, 1993
Suppression of arthritis by an inhibitor of nitric oxide synthaseN McCartney-Francis, J B Allen, D E Mizel, et al.
The American Journal of Pathology|August 1, 1987
Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patientsG Kaplan, A Nusrat, E N Sarno, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1985
Administration of recombinant interferon gamma to cancer patients enhances monocyte secretion of hydrogen peroxideC F Nathan, C R Horowitz, J de la Harpe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Phase I trial of recombinant interferon gamma in cancer patientsS Vadhan-Raj, A Al-Katib, R Bhalla, et al.
The Journal of Surgical Research|October 27, 1999
Echocardiographic and survival studies in mice undergoing endotoxic shock: effects of genetic ablation of inducible nitric oxide synthase and pharmacologic antagonism of platelet-activating factorS C Nicholson, R T Hahn, S R Grobmyer, et al.
Shock (Augusta, Ga.)|April 29, 1999
Lethality of endotoxin in mice genetically deficient in the respiratory burst oxidase, inducible nitric oxide synthase, or bothS C Nicholson, S R Grobmyer, M U Shiloh, et al.
The Journal of Experimental Medicine|April 4, 1998
Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shockC Hierholzer, B Harbrecht, J M Menezes, et al.
Blood|January 1, 1994
Hemorrhagic tumor necrosis during a pilot trial of tumor necrosis factor-alpha and anti-GD3 ganglioside monoclonal antibody in patients with metastatic melanomaL M Minasian, T P Szatrowski, M Rosenblum, et al.
Molecular Medicine (Cambridge, Mass.)|November 7, 1999
Peptidomimetic fluoromethylketone rescues mice from lethal endotoxic shockS R Grobmyer, R C Armstrong, S C Nicholson, et al.
The Journal of Experimental Medicine|August 1, 1984
Activation of human macrophages. Comparison of other cytokines with interferon-gammaC F Nathan, T J Prendergast, M E Wiebe, et al.
Pageof 12